These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 3113248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The pharmacology of aldose reductase inhibitors.
    Kador PF, Robison WG, Kinoshita JH.
    Annu Rev Pharmacol Toxicol; 1985; 25():691-714. PubMed ID: 3923907
    [No Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibitors and the complications of diabetes mellitus.
    Tomlinson DR.
    Diabet Med; 1993 Apr; 10(3):214-30. PubMed ID: 8485953
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
    Kador PF, Kinoshita JH, Sharpless NE.
    J Med Chem; 1985 Jul; 28(7):841-9. PubMed ID: 3925146
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aldose reductase inhibition and the diabetic syndrome of limited joint mobility: implications for altered collagen hydration.
    Eaton RP.
    Metabolism; 1986 Apr; 35(4 Suppl 1):119-21. PubMed ID: 3083203
    [Abstract] [Full Text] [Related]

  • 10. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL, Ramarao P.
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [Abstract] [Full Text] [Related]

  • 11. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM, Caro-Sampara F, Blicklé JF.
    Rev Med Interne; 1992 Oct; 13(1):69-79. PubMed ID: 1410879
    [Abstract] [Full Text] [Related]

  • 12. Aldose reductase inhibitors.
    Kirchain WR, Rendell MS.
    Pharmacotherapy; 1990 Oct; 10(5):326-36. PubMed ID: 2122421
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aldose reductase in the diabetic eye. XLIII Edward Jackson memorial lecture.
    Kinoshita JH.
    Am J Ophthalmol; 1986 Dec 15; 102(6):685-92. PubMed ID: 3098107
    [Abstract] [Full Text] [Related]

  • 15. Aldose reductase inhibitors: recent developments.
    Sarges R, Oates PJ.
    Prog Drug Res; 1993 Dec 15; 40():99-161. PubMed ID: 8356214
    [No Abstract] [Full Text] [Related]

  • 16. The pharmacology of diabetic complications.
    Altan VM.
    Curr Med Chem; 2003 Aug 15; 10(15):1317-27. PubMed ID: 12871132
    [Abstract] [Full Text] [Related]

  • 17. Aldose reductase inhibitors and their potential for the treatment of diabetic complications.
    Tomlinson DR, Stevens EJ, Diemel LT.
    Trends Pharmacol Sci; 1994 Aug 15; 15(8):293-7. PubMed ID: 7940997
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of aldose reductase by flavonoids: possible attenuation of diabetic complications.
    Varma SD.
    Prog Clin Biol Res; 1986 Aug 15; 213():343-58. PubMed ID: 3086893
    [No Abstract] [Full Text] [Related]

  • 19. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
    Suzen S, Buyukbingol E.
    Curr Med Chem; 2003 Aug 15; 10(15):1329-52. PubMed ID: 12871133
    [Abstract] [Full Text] [Related]

  • 20. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 15; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.